Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.72 USD | +4.42% | +0.11% | -16.01% |
Mar. 15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Mar. 13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-16.01% | 61.44M | |
+51.61% | 63.85B | |
-2.45% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.11% | 26.52B | |
-21.51% | 18.69B | |
+2.67% | 12.73B | |
+22.25% | 12.11B | |
+27.79% | 12.07B |
- Stock Market
- Equities
- CSBR Stock
- News Champions Oncology, Inc.
- Champions Oncology : Roth Capital Adjusts Price Target on Champions Oncology to $16 From $13.50, Maintains Buy Rating